scholarly article | Q13442814 |
P50 | author | Benjamin A Rogers | Q57046471 |
David L Paterson | Q59993174 | ||
P2093 | author name string | Hanna E Sidjabat | |
P2860 | cites work | NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 | Q28298371 |
Virulence factors in Escherichia coli urinary tract infection | Q28468751 | ||
Sex and virulence in Escherichia coli: an evolutionary perspective | Q28768050 | ||
The CTX-M beta-lactamase pandemic. | Q30356558 | ||
Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. | Q30369226 | ||
Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. | Q30385107 | ||
Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study | Q30389929 | ||
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. | Q33464072 | ||
Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia | Q33522349 | ||
Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients | Q33558863 | ||
Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs | Q33762110 | ||
Identification of a progenitor of the CTX-M-9 group of extended-spectrum beta-lactamases from Kluyvera georgiana isolated in Guyana. | Q33769980 | ||
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women | Q33853747 | ||
Rapid and simple determination of the Escherichia coli phylogenetic group | Q33919655 | ||
Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis | Q34046488 | ||
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome | Q34106854 | ||
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). | Q34135508 | ||
Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe | Q34198709 | ||
Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome | Q34351978 | ||
The worldwide emergence of plasmid-mediated quinolone resistance | Q34569740 | ||
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species | Q34680546 | ||
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome | Q35007119 | ||
Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community | Q36139832 | ||
Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy | Q36423625 | ||
Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing | Q36497922 | ||
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis | Q36845365 | ||
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study | Q36880729 | ||
Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France | Q36994434 | ||
Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections | Q37028442 | ||
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures | Q37144817 | ||
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region | Q37204201 | ||
Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections | Q37247785 | ||
Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004 | Q37247793 | ||
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone | Q37392921 | ||
Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. | Q37409886 | ||
Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis | Q37410500 | ||
Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada | Q37568365 | ||
Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy | Q37624439 | ||
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices | Q37694529 | ||
Chromosome-encoded Ambler class A beta-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum beta-lactamases | Q39671119 | ||
Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains | Q39787461 | ||
Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting | Q39991540 | ||
The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup | Q40003526 | ||
UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone | Q40049656 | ||
Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain | Q40328763 | ||
Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. | Q41900712 | ||
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada | Q42111425 | ||
Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline | Q42549433 | ||
CTX-M as the predominant extended-spectrum beta-lactamases among Enterobacteriaceae in Manila, Philippines | Q42574879 | ||
Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household | Q42613485 | ||
Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States | Q43007779 | ||
Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia | Q43008614 | ||
Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation | Q43105699 | ||
Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections | Q43108510 | ||
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals | Q43111830 | ||
Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors | Q43147921 | ||
Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients | Q43198027 | ||
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies | Q43206339 | ||
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog. | Q43215478 | ||
Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea | Q43237115 | ||
CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. | Q43293884 | ||
Detection of beta-lactamase-mediated resistance | Q43649165 | ||
Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread | Q44678593 | ||
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases | Q44943295 | ||
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. | Q45044150 | ||
Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand | Q45138244 | ||
Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum beta-lactamase associated with the ST131 Escherichia coli clone in Belgium. | Q45140912 | ||
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. | Q45236129 | ||
Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group | Q45278057 | ||
Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. | Q45956390 | ||
Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. | Q45956989 | ||
Emergence of imipenem resistance in clinical Escherichia coli during therapy | Q46385100 | ||
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. | Q46852401 | ||
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamases | Q47607784 | ||
Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases | Q47653135 | ||
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains | Q47714144 | ||
Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. | Q48070401 | ||
A novel IS26 structure surrounds blaCTX-M genes in different plasmids from German clinical Escherichia coli isolates. | Q51788193 | ||
AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131. | Q53174362 | ||
High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli. | Q54160713 | ||
Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. | Q54394408 | ||
Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. | Q54404451 | ||
Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system. | Q54405525 | ||
Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. | Q54454379 | ||
Escherichia coli ST131 producing CTX-M-15 in Australia | Q58455470 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
multiple drug resistance | Q643839 | ||
pandemic | Q12184 | ||
P304 | page(s) | 1-14 | |
P577 | publication date | 2010-11-16 | |
P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
P1476 | title | Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain | |
P478 | volume | 66 |
Q37109522 | A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. |
Q27011287 | A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131 |
Q40863067 | A potential camel reservoir for extended-spectrum β-lactamase-producing Escherichia coli causing human infection in Saudi Arabia |
Q36276987 | A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone |
Q36607290 | Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli |
Q51298402 | An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum β-lactamase-producing lineage in the Copenhagen area. |
Q31015114 | Analysis of the Structure and Function of FOX-4 Cephamycinase. |
Q36933460 | Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey |
Q100533695 | Antibiotic resistance and virulence of Escherichia coli strains isolated from animal rendering plant |
Q34299012 | Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model |
Q41104461 | Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia |
Q51547630 | Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes. |
Q46701351 | Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR analysis and docking studies |
Q36757725 | Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? |
Q39044602 | Application of genomic technologies to measure and monitor antibiotic resistance in animals |
Q34084784 | Are subinhibitory concentrations of antibiotics the only culprit of antibiotic resistance? |
Q41188253 | Assessment of the Prevalence of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Ready-to-Eat Salads, Fresh-Cut Fruit, and Sprouts from the Swiss Market. |
Q37979685 | Association between antimicrobial resistance and virulence in Escherichia coli. |
Q37263765 | Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups. |
Q34085171 | Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality |
Q35607916 | Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice. |
Q30390256 | Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex. |
Q30415141 | CTX-M Enzymes: Origin and Diffusion |
Q37335144 | CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA. |
Q30357611 | CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence? |
Q30407533 | CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents |
Q41480033 | CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic |
Q92603347 | Carriage and population genetics of extended spectrum β-lactamase-producing Escherichia coli in cats and dogs in New Zealand |
Q40410184 | Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand |
Q36667293 | Characteristics of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains Isolated from Multiple Rivers in Southern Taiwan. |
Q30427771 | Characteristics of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in Switzerland |
Q54291041 | Characterization of CTX-M-producing Escherichia coli by repetitive sequence-based PCR and real-time PCR-based replicon typing of CTX-M-15 plasmids. |
Q41679953 | Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study. |
Q34270772 | Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. |
Q50239001 | Characterization of Extended Spectrum Β-Lactamase Producing Enterobacteria and Methicillin-Resistant Staphylococcus aureus Isolated from Raw Pork and Cooked Pork Products in South China |
Q34236871 | Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. |
Q37026386 | Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131. |
Q53729611 | Characterization of four Escherichia coli clonal groups. |
Q36086484 | Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010) |
Q52300037 | Characterization of plasmids encoding extended-spectrum β-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK. |
Q36544359 | Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification |
Q41595384 | Clinical and microbiological determinants of infection after transrectal prostate biopsy |
Q54307864 | Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy. |
Q34596560 | Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli |
Q37001723 | Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period |
Q35607768 | Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648 |
Q36357629 | Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases |
Q94545197 | Clinically Relevant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates From Food Animals in South Korea |
Q36505534 | Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections |
Q36505381 | Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries |
Q35192273 | Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death |
Q36584908 | Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States |
Q30358381 | Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries. |
Q30395087 | Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan |
Q35289728 | Comparative genome analysis identifies few traits unique to the Escherichia coli ST131 H30Rx clade and extensive mosaicism at the capsule locus |
Q40702546 | Comparative virulotyping of extended-spectrum cephalosporin-resistant E. coli isolated from broilers, humans on broiler farms and in the general population and UTI patients |
Q35082753 | Comparison of ESBL--and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in Austria |
Q40028752 | Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. |
Q34995541 | Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)--and non-ESBL-producing uropathogenic E. coli |
Q47153650 | Complete genome sequencing and genomic characterization of two Escherichia coli strains co-producing MCR-1 and NDM-1 from bloodstream infection |
Q33622996 | Complete sequence of a KPC-producing IncN multidrug-resistant plasmid from an epidemic Escherichia coli sequence type 131 strain in China |
Q33581179 | Comprehensive Diagnosis of Bacterial Infection Associated with Acute Cholecystitis Using Metagenomic Approach |
Q36025192 | Current epidemiology and growing resistance of gram-negative pathogens |
Q36086414 | Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada |
Q40095174 | Detection of CTX-M-15 Among Uropathogenic Escherichia coli Isolated from Five Major Hospitals in Tripoli, Libya |
Q43219324 | Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae |
Q37618320 | Detection of aac(6')-Ib-cr in avian pathogenic Escherichia coli isolates in Japan |
Q38853303 | Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization-time of flight mass spectrometry |
Q40079140 | Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain |
Q33899432 | Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4. |
Q34983886 | Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates |
Q30371400 | Dissemination of IncF-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from surgical-site infections in Bangui, Central African Republic |
Q36018946 | Dissemination of pCT-like IncK plasmids harboring CTX-M-14 extended-spectrum β-lactamase among clinical Escherichia coli isolates in the United Kingdom |
Q36078069 | Diversity of Escherichia coli strains involved in vertebral osteomyelitis and arthritis in broilers in Brazil |
Q41006973 | Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia |
Q42277748 | Draft Genome Sequence Analysis of Multidrug-Resistant Escherichia coli Strains Isolated in 2013 from Humans and Chickens in Nigeria |
Q40075817 | Draft Genome Sequence of blaNDM-1-Positive Escherichia coli O25b-ST131 Clone Isolated from an Environmental Sample. |
Q41790141 | Draft Genome Sequences of Two IMP-4-Producing Escherichia coli Sequence Type 131 Isolates in Australia |
Q36951570 | Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. |
Q57794294 | Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study |
Q37876027 | Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance |
Q40945695 | Ecology of antimicrobial resistance: Special aspects of extended-spectrum β-lactamases |
Q54340974 | Editorial comment to genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli. |
Q30419770 | Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan |
Q51846180 | Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy. |
Q41907702 | Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China |
Q40294249 | Emergence of KPC-2-producing Escherichia coli isolates in an urban river in Harbin, China |
Q39101630 | Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections |
Q34575092 | Epidemic plasmid carrying bla(CTX-M-15) in Klebsiella penumoniae in China |
Q28073332 | Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis |
Q41928155 | Epidemiological characterization of a nosocomial outbreak of extended spectrum β-lactamase Escherichia coli ST-131 confirms the clinical value of core genome multilocus sequence typing |
Q38784666 | Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli |
Q37036459 | Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center. |
Q53704499 | Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea. |
Q42559358 | Escherichia coli ST131: variations on a theme of clonal expansion |
Q53133655 | Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. |
Q27015697 | Escherichia coli in Europe: an overview |
Q43230989 | Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy |
Q42574094 | Escherichia coli producing CMY-2 β-lactamase in retail chicken, Pittsburgh, Pennsylvania, USA. |
Q37264321 | Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women |
Q37562424 | Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts |
Q38201515 | Escherichia coli sequence type 131: epidemiology and challenges in treatment. |
Q26749590 | Escherichia coli β-Lactamases: What Really Matters |
Q38270555 | Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli |
Q28365034 | Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden |
Q30373052 | Evaluation of a Method Using Three Genomic Guided Escherichia coli Markers for Phylogenetic Typing of E. coli Isolates of Various Genetic Backgrounds |
Q38074212 | Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases). |
Q36727688 | Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131 |
Q31105455 | Evolutionary analyses of non-genealogical bonds produced by introgressive descent |
Q35630038 | Extended-Spectrum Beta-Lactamases Producing E. coli in Wildlife, yet Another Form of Environmental Pollution? |
Q34738249 | Extended-spectrum Beta-lactamase gene sequences in gram-negative saprophytes on retail organic and nonorganic spinach |
Q57930070 | Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae |
Q35366256 | Extended-spectrum-β-lactamase-producing Enterobacteriaceae isolated from vegetables imported from the Dominican Republic, India, Thailand, and Vietnam. |
Q64885968 | Extra-Intestinal Fluoroquinolone-Resistant Escherichia coli Strains Isolated from Meat. |
Q40045567 | Faecal carriage of CTX-M extended-spectrum beta-lactamase-producing Enterobacteriaceae among street children dwelling in Mwanza city, Tanzania |
Q36379396 | Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. |
Q57031016 | Features of urinary Escherichia coli isolated from children with complicated and uncomplicated urinary tract infections in Mexico |
Q55472567 | Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan. |
Q40240170 | First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran |
Q35066516 | First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. |
Q37264353 | Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. |
Q34494097 | Frequent combination of antimicrobial multiresistance and extraintestinal pathogenicity in Escherichia coli isolates from urban rats (Rattus norvegicus) in Berlin, Germany |
Q40988658 | Genetic Contexts of blaNDM-1 in Patients Carrying Multiple NDM-Producing Strains |
Q40263075 | Genetic characterization of fluoroquinolone resistant Escherichia coli from urban streams and municipal and hospital effluents. |
Q52640052 | Genetic contexts related to the diffusion of plasmid-mediated CTX-M-55 extended-spectrum beta-lactamase isolated from Enterobacteriaceae in China. |
Q40116355 | Genome analysis of E. coli isolated from Crohn's disease patients |
Q42849959 | Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India |
Q36439160 | Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and Their blaNDM Genetic Contexts |
Q90658001 | Genomic surveillance of Escherichia coli ST131 identifies local expansion and serial replacement of subclones |
Q34597880 | Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India |
Q47106212 | Genotypic characterization of gentamicin and cephalosporin resistant Escherichia coli isolates from blood cultures in a Norwegian university hospital 2011-2015. |
Q90218796 | Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents |
Q37711903 | Global dissemination of a multidrug resistant Escherichia coli clone |
Q36337074 | Global fluoroquinolone resistance epidemiology and implictions for clinical use. |
Q36306912 | Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli |
Q34237433 | High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam |
Q44784055 | High-throughput phenotyping of uropathogenic E. coli isolates with Fourier transform infrared spectroscopy. |
Q35960769 | Identification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in Nepal |
Q64988793 | Identification of specific protein amino acid substitutions of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli ST131: a proteomics approach using mass spectrometry. |
Q42244650 | Implementation of Fourier transform infrared spectroscopy for the rapid typing of uropathogenic Escherichia coli. |
Q35584285 | Improved detection of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli in input and output samples of German biogas plants by a selective pre-enrichment procedure |
Q38802022 | Inappropriate Empirical Treatment of Uncomplicated Cystitis in Thai Women: Lessons Learned |
Q36513085 | Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota |
Q38221132 | Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis |
Q40656286 | Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study |
Q91995139 | Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study |
Q39888407 | Industry survey of Great Britain-sourced broilers for extended-spectrum beta-lactamase and Amp C beta-lactamase-producing Escherichia coli |
Q33887625 | Infections caused by fluoroquinolone-resistant Escherichia coli following transrectal ultrasound-guided biopsy of the prostate |
Q38093459 | Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli |
Q41348043 | Insight into neonatal septicaemic Escherichia coli from India with respect to phylogroups, serotypes, virulence, extended-spectrum-β-lactamases and association of ST131 clonal group. |
Q35654610 | Integron, Plasmid and Host Strain Characteristics of Escherichia coli from Humans and Food Included in the Norwegian Antimicrobial Resistance Monitoring Programs |
Q41220729 | Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli |
Q39112302 | Lineages and virulence gene content among extended-spectrum β-lactamase-producing Escherichia coli strains of food origin in Tunisia |
Q35628250 | Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli |
Q41741261 | MLST reveals potentially high-risk international clones of Enterobacter cloacae |
Q46147802 | Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 β-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan |
Q92491726 | Meta-analysis of Pandemic Escherichia coli ST131 Plasmidome Proves Restricted Plasmid-clade Associations |
Q27000929 | Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 Clone |
Q40876635 | Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany. |
Q37504205 | Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131. |
Q57024804 | Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from the rivers and lakes in Northwest China |
Q35602248 | Molecular characterization of a multidrug resistance IncF plasmid from the globally disseminated Escherichia coli ST131 clone |
Q43097212 | Molecular characterization of bla ESBL-harboring conjugative plasmids identified in multi-drug resistant Escherichia coli isolated from food-producing animals and healthy humans |
Q37026462 | Molecular characterization of extraintestinal Escherichia coli isolates in Japan: relationship between sequence types and mutation patterns of quinolone resistance-determining regions analyzed by pyrosequencing |
Q34675362 | Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar |
Q57031890 | Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia |
Q35941378 | Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. |
Q41438937 | Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China |
Q34783513 | Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Tunisia and characterization of their virulence factors and plasmid addiction systems |
Q34315040 | Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. |
Q39485718 | Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings |
Q37263634 | Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. |
Q31079625 | Multi-locus variable number of tandem repeat analysis for rapid and accurate typing of virulent multidrug resistant Escherichia coli clones |
Q35648493 | Multidrug-Resistant and Extended Spectrum Beta-Lactamase-Producing Escherichia coli in Dutch Surface Water and Wastewater |
Q38389612 | Multidrug-resistant Escherichia coli in Asia: epidemiology and management |
Q37887250 | Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods |
Q40631519 | Multilocus sequence typing and CTX-M characterization of ESBL-producing E. coli: a prospective single-centre study in Lower Saxony, Germany |
Q42638080 | Multiple Modes of Action of a Monoclonal Antibody against Multidrug-Resistant Escherichia coli Sequence Type 131-H30. |
Q34163308 | Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance |
Q41182987 | Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage |
Q43521824 | National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain |
Q34694361 | Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals |
Q36994466 | Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar |
Q64118672 | No evidence of carbapenemase-producing Enterobacteriaceae in stool samples of 1,544 asylum seekers arriving in Rhineland-Palatinate, Germany, April 2016 to March, 2017 |
Q33837065 | No nosocomial transmission under standard hygiene precautions in short term contact patients in case of an unexpected ESBL or Q&A E. coli positive patient: a one-year prospective cohort study within three regional hospitals |
Q89823888 | Non-viable chicken embryos: an overlooked niche harbouring a significant source of multidrug resistant bacteria in the poultry production |
Q37409839 | Novel Phagocytosis-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli From Keratitis |
Q33657304 | Novel genes associated with enhanced motility of Escherichia coli ST131. |
Q42665561 | Nucleotide sequences of 16 transmissible plasmids identified in nine multidrug-resistant Escherichia coli isolates expressing an ESBL phenotype isolated from food-producing animals and healthy humans |
Q54321125 | Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses. |
Q38945913 | Occurrence of IMP-8, IMP-10, and IMP-13 metallo-β-lactamases located on class 1 integrons and other extended-spectrum β-lactamases in bacterial isolates from Tunisian rivers. |
Q39156803 | Occurrence of conjugative IncF-type plasmids harboring the blaCTX-M-15 gene in Enterobacteriaceae isolates from newborns in Tunisia |
Q36826739 | Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory |
Q39517366 | Outbreak of colonizations by extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 in a neonatal intensive care unit, Italy |
Q36204123 | Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections |
Q34035610 | Overlapped sequence types (STs) and serogroups of avian pathogenic (APEC) and human extra-intestinal pathogenic (ExPEC) Escherichia coli isolated in Brazil |
Q31047716 | Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study |
Q53811523 | Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options. |
Q50048560 | Persistent pandemic lineages of uropathogenic Escherichia coli in a college community-1999-2017. |
Q36172185 | Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. |
Q42119865 | Phylogenetic grouping and virulence potential of extended-spectrum-β-lactamase-producing Escherichia coli strains in cattle |
Q41027366 | Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins. |
Q91762200 | Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections |
Q30240591 | Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. |
Q92602528 | Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection |
Q30397339 | Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance |
Q34057927 | Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. |
Q41372349 | Prevalence and characteristics of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from rural well water in Taian, China, 2014. |
Q37026380 | Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark |
Q54261009 | Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in spring waters. |
Q35589184 | Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia |
Q30401450 | Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs |
Q36172561 | Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population |
Q57300295 | Prevalence of Multidrug Resistance and Extended-Spectrum -Lactamase Carriage of Clinical Uropathogenic Isolates in Riyadh, Saudi Arabia |
Q40562293 | Prevalence of O25b-ST131 clone among Escherichia coli strains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases |
Q41010675 | Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy |
Q46949126 | Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. |
Q36174026 | Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013. |
Q37586998 | Prevalent combination of virulence and plasmidic-encoded resistance in ST 131 Escherichia coli strains |
Q42931296 | Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone |
Q27001490 | Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections |
Q37623615 | Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014. |
Q36086404 | Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia |
Q38780024 | Public health risk of antimicrobial resistance transfer from companion animals. |
Q37713679 | Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. |
Q34916386 | Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. |
Q54328207 | Real-time PCR for detection of blaOXA-48 genes from stools. |
Q35364501 | Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli. |
Q37349628 | Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration. |
Q37998398 | Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example |
Q36295546 | Resistance to antimicrobial drugs in different surface waters and wastewaters of Guadeloupe |
Q37290720 | Resistant gram-negative infections in the outpatient setting in Latin America |
Q46919326 | Risk Factors and Molecular Features of Sequence Type (ST) 131 Extended-spectrum β-Lactamase-producing Escherichia coli in Community-onset Bacteremia |
Q54992441 | Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections. |
Q36558824 | Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli |
Q39090124 | Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial |
Q50097358 | Selection of ESBL-Producing E. coli in a Mouse Intestinal Colonization Model. |
Q38391440 | Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
Q41934448 | Silver resistance genes are overrepresented among Escherichia coli isolates with CTX-M production |
Q28600869 | Social structure and Escherichia coli sharing in a group-living wild primate, Verreaux's sifaka |
Q37713676 | Spread of CTX-M-15 extended-spectrum β-lactamase-producing Escherichia coli isolates through household contact and plasmid transfer |
Q36902491 | Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. |
Q38294759 | Suppression of type 1 pilus assembly in uropathogenic Escherichia coli by chemical inhibition of subunit polymerization |
Q28082571 | Surveillance of antibiotic resistance |
Q42259493 | Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases |
Q54320019 | Survival of pathogenic Escherichia coli on basil, lettuce, and spinach. |
Q42930222 | Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and Coresistance phenotype among recent Escherichia coli isolates from U.S. veterans |
Q37458279 | Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. |
Q30393531 | Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics |
Q36061308 | Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe |
Q34596717 | Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012. |
Q34431394 | The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities |
Q47158818 | The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015 |
Q97071024 | The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016 |
Q97072646 | The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017 |
Q57035779 | The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131 |
Q35120750 | The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide |
Q41220445 | The challenges of treating women with recurrent urinary tract infections in primary care: a qualitative study of GPs' experiences of conventional management and their attitudes towards possible herbal options |
Q30375493 | The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation. |
Q38497797 | The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae |
Q48044609 | The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel. |
Q34465593 | The emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China. |
Q37408471 | The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx |
Q40299603 | The evolutionary path to extraintestinal pathogenic, drug-resistant Escherichia coli is marked by drastic reduction in detectable recombination within the core genome |
Q90101011 | The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subclone |
Q35158603 | The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli |
Q38197399 | The resistance tsunami, antimicrobial stewardship, and the golden age of microbiology |
Q36262549 | The role of H4 flagella in Escherichia coli ST131 virulence |
Q35008859 | The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. |
Q48055285 | Transfer of an Escherichia coli ST131 multiresistance cassette has created a Klebsiella pneumoniae-specific plasmid associated with a major nosocomial outbreak. |
Q36218305 | Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting |
Q60924381 | Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates: 12-year ecological study using a nationwide surveillance and antimicrobial prescription database |
Q36683661 | Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic Aspects |
Q35071905 | Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan. |
Q39921783 | Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals. |
Q40041086 | Uropathogenic Escherichia coli ST131 in urinary tract infections in children |
Q35960847 | Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations |
Q43088258 | Verona integron-encoded metallo-β-lactamase 1 in Enterobacteria, Ontario, Canada. |
Q64119449 | Virulence factors, prevalence and potential transmission of extraintestinal pathogenic isolated from different sources: recent reports |
Q35867575 | Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype |
Q30414720 | Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. |
Q40188898 | Wastewater treatment plants release large amounts of extended-spectrum β-lactamase-producing Escherichia coli into the environment. |
Q35746364 | Who is leading this dance? Understanding the spread of Escherichia coli sequence type 131 |
Q58793609 | Whole genome analyses of CMY-2-producing Escherichia coli isolates from humans, animals and food in Germany |
Q40064103 | Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand |
Q91899356 | Whole genome sequencing of extended-spectrum β-lactamase genes in Enterobacteriaceae isolates from Nigeria |
Q64236885 | Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes |
Q30389643 | Wide dissemination of extended-spectrum β-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula |
Q37942654 | Will new antimicrobials overcome resistance among Gram-negatives? |
Q42203025 | blaCTX-M-₁₅-carrying Escherichia coli and Salmonella isolates from livestock and food in Germany. |
Q36644786 | β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates |
Q37035803 | β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula |
Search more.